Top Biotech Companies in Houston, TX (79)
DM Clinical Research is a multi-therapeutic network of clinical trial investigator sites headquartered in Houston, Texas. Founded in 2006, the company connects patients with trusted physicians to conduct cutting-edge research focused on quality and compassion, aiming to deliver advanced, preventative medicine to underserved communities. They operate a national network of dedicated research centers and physician-embedded sites throughout the United States.
ARTIDIS AG is a clinical-stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. By combining its proprietary nanotechnology platform for rapid tissue analysis with a holistic data solution, ARTIDIS accelerates drug discovery, tissue engineering, and personalized treatment. The company focuses its research and development efforts on solid tumors to enhance responses to...
For more than four decades, BioReference has built a legacy based on scientific excellence, innovation and world-class service in laboratory testing solutions. Amidst a tidal wave of change in healthcare in recent years, BioReference has evolved, adding significant services and solutions aimed at addressing the needs of today’s customers. Laboratory testing remains the cornerstone to the services we provide. As...
Medical Metrics, Inc. (MMI) is an ISO-certified, full‑service medical imaging core laboratory that provides centralized, independent image review, protocol and endpoint development, image management, and scientific consulting for multicenter clinical trials. MMI supports device, biotech, and pharmaceutical sponsors across therapeutic areas and also develops AI-enabled imaging tools (SpineCAMP™) to standardize and automate radiographic assessments.
Covestro is one of the world’s leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. Covestro supplies customers around the world in key industries such as mobility, building and living, as well as the electrical and electronics sector. In addition,...
Covestro's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests Covestro holds top-tier, often #1, positions in polycarbonate and select specialty coating precursors, underpinned by global, multi-site capacity. Evidence also points to recognized strategic importance and deep technology/application know-how across polyurethane inputs, even if not the largest in every sub-market.
Future-Ready Strategy: Feedback suggests the company has clear climate-neutrality and circularity targets and is executing a multi-year transformation program alongside selective specialty acquisitions. These actions aim to shift the mix toward higher-value applications and position the portfolio for recovery when pricing and demand normalize.
Investor Backing & Capital Strength: Feedback suggests majority ownership by ADNOC/XRG and a completed capital increase provide stronger financial backing and optionality for investment. Regulatory clearances and integration steps indicate committed sponsorship that could support medium-term growth initiatives.
As a leading Integrated Research Organization (IRO), we partner with major healthcare systems to embed clinical trials at the point of care, connecting patients to research through physicians they already trust, in the communities they already love. Our model unlocks access to broader, more diverse populations, driving faster enrollment, stronger retention, and richer data. With centralized resources and streamlined operations,...
Westlake Chemical (NYSE: WLK) is a quality manufacturer and dependable global supplier of petrochemicals, plastics and building products. Our mission is to serve our clients by enhancing daily life through the products and services we provide, which in turn make life better for people every day. Employing approximately 9,500 people, Westlake operates from 36 locations in North America, 11 in Europe...
Westlake Chemical Corporation's Top Stability & Growth Strengths
Strong Market Position & Advantage: Westlake is widely viewed as a top‑tier PVC and chlor‑alkali producer with a leading LDPE footprint and strong North American building‑products platforms. Vertical integration from chlorine/EDC/VCM and PVC into downstream products supports cost position and market reach.
Diversified Revenue Streams: Two segments—Performance & Essential Materials and Housing & Infrastructure Products—span upstream chemicals through branded building products. HIP has been comparatively steadier than PEM, moderating overall cyclicality.
Future-Ready Strategy: Strategic acquisitions (Axiall, Hexion Epoxy, Boral/Westlake Royal, ACI) and sustainability offerings (e.g., GreenVin PVC, ISCC PLUS certification) broaden specialty exposure and align to evolving customer needs. Management is executing footprint optimization and a PEM profitability plan targeting improvement in 2026.
BiVACOR is a clinical-stage medical device company pioneering the development of a long-term therapy for patients with biventricular heart failure, aiming to provide life-extending solutions for end-stage heart failure.
We Engineer Solutions for the Nation’s Toughest Problems As an independent nonprofit engineering innovation company, Draper provides engineering services directly to government, industry, and academia. We work on teams as prime contractors or subcontractors and participate as collaborators in consortia. Our strong commitment to delivering working solutions allows us to apply ourselves to a variety of domains from space to undersea —...
Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We are committed to sustainability by responsibly managing the materials we create for their entire lifecycle and are growing our portfolio of sustainable...
Xylem |ˈzīləm| 1) The tissue in plants that brings water upward from the roots; 2) a leading global water technology company. Xylem, a leading global water technology company dedicated to solving the world’s most challenging water issues, is the leading global provider of efficient, innovative and sustainable water technologies improving the way water is used, managed, conserved and re-used. Our international team is...
Gene by Gene offers a wide range of affordable genetic testing lab services using cutting-edge biotechnology, giving unparalleled insight into ourselves and our future.
RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory...
Forge Biologics is a gene therapy contract development and manufacturing organization (CDMO) and clinical-stage therapeutics developer. The company helps scientists, physicians, biotechnology and pharmaceutical companies, and patient groups bring life-changing gene therapies from concept to patients. Its end-to-end capabilities include plasmid and AAV manufacturing, process and analytical development, cGMP production, fill and finish, and integrated regulatory support for transformative medicines...
Pace® works with organizations of all types, providing the science to ensure our air, water, therapies, and more are safe for use. Learn more about our laboratory services at PACELABS.com.
Pace Labs's Top Stability & Growth Strengths
Strong Market Position & Advantage: Pace is widely characterized as a U.S. leader in environmental testing with standout PFAS credentials, including multi‑method DoD accreditations and repeated industry recognition. Life‑sciences credibility is evidenced by FDA‑inspected sites and Top CDMO recognition, with leadership most pronounced in specific U.S. niches.
Market Expansion: The company has materially expanded its footprint via acquisitions (e.g., Alpha Analytical, ESL, Agra) and site adds, bringing the U.S. network to roughly 125–127 labs and service centers by late 2024. Life‑sciences additions (Curia NJ, Catalent RTP) and new centers and facilities further extend reach and capacity.
Future-Ready Strategy: Capacity investments target high‑growth areas such as sterile fill‑finish, biologics, gene therapy, and advanced PFAS methods, alongside positive FDA inspections and new centers of excellence. Backing for expansions, including a state‑supported buildout, indicates preparation for rising regulated testing and advanced therapy demand.
Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics. Our novel approach integrates clinical operations excellence, with laboratory expertise, and advanced data sciences to inform every step. This maximizes our clients’ insight into patient biology, delivering more predictable trial outcomes and accelerating clinical development. We apply...
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the...
As a global healthcare company, we understand customer needs and innovate and deliver medical solutions that transform patient care. Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide...
Merit Medical Systems, Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show rising revenue through 2025 with further growth in early 2026, and guidance points to continued expansion for the full year. Feedback suggests demand is broad-based across the U.S. and faster-growing international regions.
Profitability: Gross margin improved year over year and non‑GAAP operating margin edged higher in the latest quarter, indicating operating leverage alongside growth. Free cash flow also increased, and management targets further margin improvement.
Strong Market Position & Advantage: The company reports leadership in core disposable niches such as inflation devices, control syringes, hemostasis/waste systems, tubing/manifolds, as well as SCOUT breast localization and embolotherapy microspheres. Independent industry sources list the firm among top players in hemostasis valves and embolization particles.
Baylor Genetics is a joint venture of H.U. Group Holdings, Inc. and Baylor College of Medicine, including the #1 NIH-funded Department of Molecular and Human Genetics. Located in Houston’s Texas Medical Center, Baylor Genetics serves clients in 50 states and 16 countries.
As the world's largest fully integrated producer of PA66, we designed our vertically integrated manufacturing process to ensure quality, consistency and supply security. Headquartered in Houston, Texas, Ascend has nine global locations, including five fully integrated manufacturing facilities in the southeastern United States and an engineering plastics compounding facility in Europe, all dedicated to the innovation and safe production of nylon...
